Biotech Values

[DewDiligence]

RVNC—Management hires include AGN’s head of international commercial operations:

https://www.businesswire.com/news/home/20180402005685/en/

Revance Therapeutics…today announced the appointments of Dustin Sjuts as Vice President of Strategy and Sales, Aesthetic and Therapeutic; Ben Putman as Vice President of Digital; and Marc Korenberg as Senior Director of Commercial Operations. In addition, Erica Bazerkanian has been promoted to Vice President of Marketing, Aesthetics and Therapeutics.

All four positions are newly established and will report to Todd Zavodnick, Chief Commercial Officer and President, Aesthetics & Therapeutics, who leads the company’s commercial operations and launch preparations for DaxibotulinumtoxinA for Injection (RT002) in the treatment of glabellar (frown) lines.

In his new role at Revance, Mr. Sjuts will head all product sales activities, championing strategies to enhance physician relations and drive new product adoption. Most recently, he held leadership positions at Nestle Skin Health, including Business Unit Head in China and Senior Director of Marketing in the U.S. In China, he was responsible for the medical aesthetics commercial organization, leading the development and execution of the medical solutions strategy. Prior to this, Mr. Sjuts was Senior Vice President of Franchise Operations for Alphaeon. Previously, he served as Director of Sales in Eye Care and as Senior Regional Manager of Aesthetics at Allergan.

…In his new role, Mr. Korenberg will manage commercial operations activities at Revance, including customer excellence and relationship management, commercial analytics, commercial programs, and commercial financial management. Most recently, he was Director of Commercial, International at Allergan, after the acquisition of Zeltiq Aesthetics, Inc., where Marc served as the Director of International Finance and Operations.